Table 1. Characteristics of confirmed SARS-COV-2 reinfection cases.
Author | Country | Number of cases | Age in years | Co-morbidities | Symptoms at 1st episode | Time (weeks) between 1st and 2nd episode | Symptoms at 2nd episode | Onward transmission from 2nd episode |
---|---|---|---|---|---|---|---|---|
Tillett RL et al. [11] | USA | 1 | 25 | No | Sore throat, cough, headache, nausea, diarrhoea | 6 | Fever, headache, dizziness, cough, nausea, diarrhoea, shortness of breath | NR |
Mulder M et al. [58] | Netherlands | 1 | 89 | Yes | Fever, severe cough | 8 | Fever, cough, dyspnoea, tachypnoea | NR |
Prado-Vivar B et al. [59] | Ecuador | 1 | 46 | No | Headache, drowsiness | 9 | Odynophagia, nasal congestion, fever, back pain, productive cough, dyspnoea | NR |
To KK et al. [49] | Hong Kong | 1 | 33 | No | Productive cough, sore throat, fever, headache | 10 | Asymptomatic | NR |
Van Elslande J et al. [48] | Belgium | 1 | 51 | Yes | Headache, fever, myalgia, cough, chest pain, dyspnoea, anosmia, change of taste | 12 | Headache, cough, fatigue | NR |
Colson P et al. [50] | France | 1 | 70 | Yes | Fever, cough | 15 | Asymptomatic | NR |
Goldman JD et al. [42] | USA | 1 | 60–69 | Yes | Fever, chills, productive cough, dyspnoea, chest pain | 20 | Dyspnoea, dry cough, weakness | NR |
Harrington D et al. [34] | UK | 1 | 78 | Yes | Fever | 32 | Shortness of breath | NR |
Lee JS et al. [41] | South Korea | 1 | 21 | No | Sore throat, cough | 3 | Sore throat, cough | NR |
Gupta V et al. [43] | India | 2 | 25–28 | No | Asymptomatic | 9–14 | Asymptomatic | NR |
Selhorst P et al. [60] | Belgium | 1 | 39 | NR | Cough, dyspnoea, headache, fever, general malaise | 26.5 | Mild symptoms | Unclear |
Pérez-Lago L et al* [14] | Spain | 1 | 53 | Yes | Dyspnoea, fever, cough | 20 | Respiratory failure | Yes |
* Phylogenetically confirmed but does not meet RKI confirmed reinfection criteria,
NR not reported.